Amneal Pharmaceuticals Cash from Operations (TTM) Trends

Amneal Pharmaceuticals Inc (AMRX)

6.47 -0.12 (-1.82%) USD | NASDAQ | May 09, 16:00

6.47 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	201.46M
December 31, 2023	345.58M
September 30, 2023	186.46M
June 30, 2023	198.64M
March 31, 2023	84.47M
December 31, 2022	65.10M
September 30, 2022	151.65M
June 30, 2022	140.45M
March 31, 2022	214.04M
December 31, 2021	241.82M
September 30, 2021	284.52M

Date	Value
June 30, 2021	246.93M
March 31, 2021	478.10M
December 31, 2020	379.00M
September 30, 2020	222.15M
June 30, 2020	317.29M
March 31, 2020	159.14M
December 31, 2019	1.705M
September 30, 2019	312.24M
June 30, 2019	234.46M
March 31, 2019	114.79M
December 31, 2018	250.23M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

1.705M

Minimum

Dec 2019

478.10M

Maximum

Mar 2021

223.26M

Average

218.09M

Median

Cash from Operations (TTM) Benchmarks